Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms: Post hoc analyses of three randomized controlled trials-Reference-Cited by-同舟云学术

Fluticasone furoate/vilanterol once daily improves night-time awakenings in asthma patients with night symptoms: Post hoc analyses of three randomized controlled trials

Published:2018-07-24 Issue:8 Volume:55 Page:890-897
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Kerwin Edward¹,Barnes Neil²,Gibbs Michael²,Leather David²,Forth Richard³,Jacques Loretta⁴,Yates Louisa J.²

Affiliation:

1. Clinical Research Institute of Southern Oregon, Medford, OR, USA

2. Respiratory Medical Franchise, GSK, Brentford, UK

3. Quantitative Sciences Division, GSK, Research Triangle Park, NC, USA

4. Respiratory Medicines Development Centre, GSK, Uxbridge, UK

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2017.1362429

Reference14 articles.

1. Self-perceived Sleep Quality and Quantity in Adults With Asthma: Findings From the CosteAsma Study

2. Global Initiative for Asthma (GINA). 2016 GINA Report, Global Strategy for Asthma Management and Prevention. Available from: http://ginasthma.org

3. Underdiagnosis of Nocturnal Symptoms in Asthma in General Practice

4. Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fixed combination of vilanterol triphenatate/fluticasone furoate in the treatment of patients with bronchial asthma and chronic obstructive pulmonary disease: a literature review;Meditsinskiy sovet = Medical Council;2022-01-06

2. Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma;Cogent Medicine;2019-01-01

3. Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences;Advances in Therapy;2018-08-13